Personalizing the Management of Men with Intermediate-risk Prostate Cancer

被引：6
|
作者：
D'Amico, Anthony V. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
EUROPEAN UROLOGY | 2013年 / 64卷 / 06期
关键词：
GLEASON SCORE; DISEASE; MORTALITY; BIOPSIES;
D O I：
10.1016/j.eururo.2013.03.038
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：903 / 904
页数：2
相关论文
共 50 条
  • [1] Personalizing the Duration of Androgen-Deprivation Therapy Use in the Management of Intermediate-Risk Prostate Cancer
    D'Amico, Anthony V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (04) : 301 - U151
  • [2] Intermediate-risk Prostate Cancer: Stratification and Management
    Preisser, Felix
    Cooperberg, Matthew R.
    Crook, Juanita
    Feng, Felix
    Graefen, Markus
    Karakiewicz, Pierre I.
    Klotz, Laurence
    Montironi, Rodolfo
    Nguyen, Paul L.
    D'Amico, Anthony V.
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (03): : 270 - 280
  • [3] Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer
    Diven, Marshall A.
    Tshering, Lhaden
    Ma, Xiaoyue
    Hu, Jim C.
    Barbieri, Christopher
    McClure, Timothy
    Nagar, Himanshu
    [J]. JAMA NETWORK OPEN, 2024, 7 (08)
  • [4] Outcomes for Men with Intermediate-risk Prostate Cancer on Active Surveillance
    Courtney, P. T.
    Deka, R.
    Cherry, D. R.
    Nelson, T. J.
    Luterstein, E.
    Salans, M. A.
    Yip, A. T. T.
    Nalawade, V.
    Parsons, J. K.
    Kader, K.
    Stewart, T. F.
    Rose, B. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S121 - S122
  • [5] Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer
    Cooperberg, Matthew R.
    Cowan, Janet E.
    Hilton, Joan F.
    Reese, Adam C.
    Zaid, Harras B.
    Porten, Sima P.
    Shinohara, Katsuto
    Meng, Maxwell V.
    Greene, Kirsten L.
    Carroll, Peter R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 228 - 234
  • [6] UTILITY OF ONCOTYPE DX IN MEN WITH INTERMEDIATE-RISK PROSTATE CANCER
    Cantu, Miguel
    Golan, Ron
    McCarthy, Hiral
    Scognamiglio, Theresa
    McClure, Timothy
    Barbieri, Christopher
    Robinson, Brian
    Khani, Francesca
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E207 - E207
  • [7] Insignificant disease among men with intermediate-risk prostate cancer
    Hong, Sung Kyu
    Vertosick, Emily
    Sjoberg, Daniel D.
    Scardino, Peter T.
    Eastham, James A.
    [J]. WORLD JOURNAL OF UROLOGY, 2014, 32 (06) : 1417 - 1421
  • [8] Management of low- and intermediate-risk prostate cancer
    Henk van der Poel
    Laurence Klotz
    Christian G. Stief
    [J]. World Journal of Urology, 2015, 33 : 905 - 906
  • [9] Management of low- and intermediate-risk prostate cancer
    van der Poel, Henk
    Klotz, Laurence
    Stief, Christian G.
    [J]. WORLD JOURNAL OF UROLOGY, 2015, 33 (07) : 905 - 906
  • [10] Insignificant disease among men with intermediate-risk prostate cancer
    Sung Kyu Hong
    Emily Vertosick
    Daniel D. Sjoberg
    Peter T. Scardino
    James A. Eastham
    [J]. World Journal of Urology, 2014, 32 : 1417 - 1421
12345